Evan Walker

Evan Walker, MD, is an Assistant Professor in the Department of Medicine at the University of California, San Francisco (UCSF), School of Medicine. He is a medical oncologist specializing in gastrointestinal cancers, with active clinical practices at both UCSF and the San Francisco VA Health Care System. His research and clinical work focus on pancreatic and colorectal cancers, integrating molecular profiling, germline testing, and novel therapeutic strategies.

• Institution: University of California, San Francisco
• School: School of Medicine
• Department: Department of Medicine
• Academic Rank: Assistant Professor
• Clinical Sites: UCSF, San Francisco VA

Dr. Walker's research interests center on improving outcomes in gastrointestinal malignancies, particularly through precision oncology, health equity, and clinical trial design. He investigates maintenance therapies for metastatic pancreatic cancer, the role of HDAC inhibitors like ivaltinostat, and the implementation of germline and molecular testing in routine care. His work also extends to palliative care, advance care planning, and the psychosocial aspects of cancer in diverse and veteran populations. He has contributed significantly to understanding therapeutic toxicities, health disparities, and innovative models for genetic counseling and testing delivery.

The 15 most recent publications highlight a strong focus on pancreatic cancer therapeutics, especially maintenance regimens post-FOLFIRINOX, and the integration of molecular and germline testing. There is also a recurring theme of patient-centered care, health services research, and equity, particularly in veteran and underserved populations. His work spans clinical trials, observational studies, and narrative medicine, reflecting a holistic approach to oncology.

Dr. Walker has not received any explicitly mentioned scientific awards in the provided text.

He is actively involved in mentoring and advising, although no specific students are listed. His research is supported through clinical trials and institutional collaborations, particularly with Dr. Andrew Ko and teams at UCSF and the VA. His work has been referenced in patents and clinical guidelines, indicating translational impact.

Dr. Walker is associated with clinical and research teams focused on gastrointestinal oncology, cancer genetics, and veteran health. He participates in academic senate committees and is embedded in a network of co-authors and collaborators advancing pancreatic cancer research and care delivery innovation.